Frazier Healthcare Partners logo

Frazier Healthcare Partners

North America, Washington, United States, Seattle

Description

Frazier Healthcare Partners is a healthcare investment firm for pharmaceuticals, healthcare services, & medical products.

Investor Profile

Frazier Healthcare Partners has made 221 investments, with 1 in the past 12 months and 24% as lead.

Stage Focus

  • Series B (23%)
  • Series A (22%)
  • Series C (13%)
  • Post Ipo Equity (11%)
  • Series D (10%)
  • Series Unknown (10%)
  • Undisclosed (3%)
  • Series E (3%)
  • Private Equity (2%)
  • Post Ipo Debt (1%)

Country Focus

  • United States (95%)
  • Canada (1%)
  • Ireland (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Medical Device
  • Biopharma
  • Life Science
  • Health Diagnostics
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Frazier Healthcare Partners frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 19
Canaan Partners
North America, California, United States, Menlo Park
Co-Investments: 14
Domain Associates
North America, California, United States, San Diego
Co-Investments: 18
InterWest Partners
North America, California, United States, Menlo Park
Co-Investments: 13
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 20
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 17
Versant Ventures
North America, California, United States, Menlo Park
Co-Investments: 16
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 12
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 17
Delphi Ventures
North America, California, United States, San Mateo
Co-Investments: 13

Which angels does Frazier Healthcare Partners often collaborate with?

AZ
North America, California, United States, Mountain View
Shared Deals: 2
SA
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Frazier Healthcare Partners?

Day One Biopharmaceuticals

South San Francisco, California, United States

Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.

BiopharmaBiotechnologyHealth CarePharmaceutical
Post Ipo EquityJul 30, 2024
Amount Raised: $175,000,000
Curve Beam

Hatfield, Pennsylvania, United States

Curve Beam is a manufacturer that researches and designs cone beam CT imaging equipment for orthopedic specialties.

ManufacturingMedicalMedical Device
Series UnknownJan 31, 2023
Amount Raised: $25,000,000
New Amsterdam Pharma

Naarden, Noord-Holland, The Netherlands

New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.

BiotechnologyLife SciencePharmaceutical
Post Ipo EquityNov 23, 2022
Amount Raised: $235,000,000
Metagenomi

Emeryville, California, United States

Metagenomi uses metagenomics and machine learning to discover novel genome editing systems for therapeutics development.

Artificial Intelligence (AI)BiotechnologyMachine LearningTherapeutics
Series BJan 25, 2022
Amount Raised: $175,000,000
Pardes Biosciences

Carlsbad, California, United States

Pardes Biosciences is a biotechnology company that develops and commercializes direct-acting antivirals for the treatment of coronavirus.

BiotechnologyLife Science
Post Ipo EquityDec 27, 2021
Amount Raised: $75,000,000
SanReno Therapeutics

Beijing, Beijing, China

SanReno Therapeutics develop, manufacture and commercialize kidney disease therapies.

BiotechnologyHealth CareTherapeutics
UndisclosedNov 30, 2021
Amount Raised: $40,000,000
Tricida

Menlo Park, California, United States

Tricida operates in the healthcare industry focusing on pharmaceutical business.

Health CareMedicalPharmaceutical
Post Ipo EquityNov 15, 2021
Amount Raised: $42,000,000
Silence Therapeutics

London, England, United Kingdom

Silence Therapeutics is a drug development company with a proprietary genetic medicine platform.

BiotechnologyHealth CareInformation TechnologyMedicalTherapeutics
Post Ipo EquityNov 5, 2021
Amount Raised: $20,000,000
Scout Bio

Philadelphia, Pennsylvania, United States

Scout Bi is a biotechnology company that specializes in veterinary, animal health, and gene therapy.

BiotechnologyGeneticsHealth CareTherapeutics
Series BOct 19, 2021
Amount Raised: $33,000,000
Gritstone bio

Emeryville, California, United States

Gritstone bio is a biotechnology company that develops immunotherapies for cancer and infectious diseases.

BiotechnologyHealth CareTherapeutics
Post Ipo EquitySep 16, 2021
Amount Raised: $55,000,000